- Main
- Biography & Autobiography - Business & Finance
- The Antidote: Inside the World of New...
The Antidote: Inside the World of New Pharma
Barry WerthHow much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
IN THE ANTIDOTE, Barry Werth draws upon unprecedented inside reporting spanning more than two decades to provide a groundbreaking closeup of the upstart pharmaceutical company Vertex and the ferocious but indispensable world of Big Pharma that it inhabits.
In 1989, the charismatic Joshua Boger left Merck, then America’s most admired business, to found a drug company that would challenge industry giants and transform health care. Werth described the company’s tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell a riveting story of Vertex’s bold endurance and eventual success.
The $325 billion-a-year pharmaceutical business is America’s toughest and one of its most profitable. It’s riskier and more rigorous at just about every stage than any other business, from the towering biological uncertainties inherent in its mission to treat disease; to the 30-to-1 failure rate in bringing out a successful medicine even after a molecule clears all the hurdles to get to human testing; to the multibillion-dollar cost of ramping up a successful product; to operating in the world’s most regulated industry, matched only by nuclear power.
Werth captures the full scope of Vertex’s twentyfive- year drive to deliver breakthrough medicines. At a time when America struggles to maintain its innovative edge, The Antidote is a powerful inside look at one of the most intriguing and important business stories of recent decades.
In 1989, the charismatic Joshua Boger left Merck, then America’s most admired business, to found a drug company that would challenge industry giants and transform health care. Werth described the company’s tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell a riveting story of Vertex’s bold endurance and eventual success.
The $325 billion-a-year pharmaceutical business is America’s toughest and one of its most profitable. It’s riskier and more rigorous at just about every stage than any other business, from the towering biological uncertainties inherent in its mission to treat disease; to the 30-to-1 failure rate in bringing out a successful medicine even after a molecule clears all the hurdles to get to human testing; to the multibillion-dollar cost of ramping up a successful product; to operating in the world’s most regulated industry, matched only by nuclear power.
Werth captures the full scope of Vertex’s twentyfive- year drive to deliver breakthrough medicines. At a time when America struggles to maintain its innovative edge, The Antidote is a powerful inside look at one of the most intriguing and important business stories of recent decades.
Categories:
Year:
2014
Publisher:
Simon & Schuster
Language:
english
Pages:
448
ISBN 10:
1451655665
ISBN 13:
9781451655667
File:
EPUB, 2.03 MB
Your tags:
IPFS:
CID , CID Blake2b
english, 2014
The file will be sent to your email address. It may take up to 1-5 minutes before you receive it.
The file will be sent to you via the Telegram messenger. It may take up to 1-5 minutes before you receive it.
Note: Make sure you have linked your account to Z-Library Telegram bot.
The file will be sent to your Kindle account. It may take up to 1–5 minutes before you receive it.
Please note: you need to verify every book you want to send to your Kindle. Check your mailbox for the verification email from Amazon Kindle.
Conversion to is in progress
Conversion to is failed
Premium benefits
- Send to eReaders
- Increased download limit
- File converter
- More search results
- More benefits